[Pathologico-anatomical aspects of leptomeningitis tuberculosa treated by streptomycin, PAS and TB1].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D016920:Meningitis, Bacterial; D013307:Streptomycin / Q000627:therapeutic use*; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014376:Tuberculosis; D014390:Tuberculosis, Meningeal / Q000628:therapy*
D013882:Thiosemicarbazones; D010131:Aminosalicylic Acid; D013307:Streptomycin
PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; THIOSEMICARBAZONES/therapeutic use; TUBERCULOSIS, MENINGEAL/therapy
Pathologisch-anatomischer Beitrag zur Frage der Leptomeningitis tuberculosa unter Streptomycin-, PAS- und TB I-Behandlung.